Global drugmakers face a hit to earnings from 2011, as they are forced to chip in to help pay for US healthcare reform, but will benefit in the long run as millions more Americans become customers for their medicines

In an attempt to negate the debate around animal testing, plans for a new test subject for drugs are being implemented. But, could a virtual human do away with the need for animal testing?

Allon Therapeutics Inc. has a drug candidate and an innovative strategy to impress any investor

Researchers have found a drug-free way to block fearful memories, opening up the possibility of new treatment approaches for problems such as post traumatic stress disorder

An experimental breast cancer drug made from sea sponges adds months to the lives of breast cancer patients

GlaxoSmithKline stepped up its drive in emerging markets with the acquisition of Laboratorios Phoenix for $253m

Large pharmaceutical companies struggle to supply roles to talented researchers

Mind-altering drugs could be combined with psychotherapy to treat people suffering from depression or chronic pain

Governments around the world could save huge health costs and avert millions of early deaths if they introduced laws to cut salt levels in food, a top World Health Organisation (WHO) nutrition adviser has claimed

Large firm creates a novel molecular diagnostic test to detect colorectal cancer, the second leading cancer killer

European scientists have found a full range of markers in the blood of kidney transplant patients which could predict whether their new organ will be a success and whether they need large amounts of medication to help it

At a recent dinner to honor the achievements of Henri Termeer, chief executive of biotechnology company Genzyme, Ananth Raman broke down as he recalled the moment he learned his 7-month old daughter had Pompe disease, a rare genetic disorder that was damaging her heart. It was 2005 and doctors told him there was no cure. His child, they said, probably had less than five months to live